127 related articles for article (PubMed ID: 6337291)
21. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.
Poli G; Introna M; Zanaboni F; Peri G; Carbonari M; Aiuti F; Lazzarin A; Moroni M; Mantovani A
Clin Exp Immunol; 1985 Oct; 62(1):128-35. PubMed ID: 2415279
[TBL] [Abstract][Full Text] [Related]
22. A monoclonal antibody (VEP10) against an antigen shared by human large granular lymphocytes, thymocytes and activated T cells.
Rumpold H; Kraft D; Obexer G; Böck G; Möschl P
Immunology; 1983 Jun; 49(2):265-72. PubMed ID: 6602090
[TBL] [Abstract][Full Text] [Related]
23. Natural killing (NK) potential of cord blood lymphocytes.
Toder V; Durdana A; Elrad H; Gleicher N
J Clin Lab Immunol; 1985 May; 17(1):29-32. PubMed ID: 4045996
[TBL] [Abstract][Full Text] [Related]
24. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
Barlozzari T; Reynolds CW; Herberman RB
J Immunol; 1983 Aug; 131(2):1024-7. PubMed ID: 6863925
[TBL] [Abstract][Full Text] [Related]
25. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
Rumpold H; Kraft D; Gastl G; Huber C
Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
[TBL] [Abstract][Full Text] [Related]
26. Lymphocytes infiltrating ovarian carcinoma: modulation of functional activity by intraperitoneal treatment with biological response modifiers.
Allavena P; Peri G; Di Bello M; Peccatori F; Chiaffarino F; Pirovano P; Mantovani A
Nat Immun Cell Growth Regul; 1988; 7(4):230-8. PubMed ID: 3070372
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
28. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
Reynolds CW; Timonen T; Herberman RB
J Immunol; 1981 Jul; 127(1):282-7. PubMed ID: 7240744
[TBL] [Abstract][Full Text] [Related]
29. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer.
Peoples GE; Goedegebuure PS; Andrews JV; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5481-91. PubMed ID: 8228240
[TBL] [Abstract][Full Text] [Related]
30. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
Rees RC; Reynolds CW; Herberman RB
Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
[TBL] [Abstract][Full Text] [Related]
31. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
32. Morphological characterization of a cell population responsible for natural killer activity.
Luini W; Boraschi D; Alberti S; Aleotti A; Tagliabue A
Immunology; 1981 Aug; 43(4):663-8. PubMed ID: 7275171
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
34. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
[TBL] [Abstract][Full Text] [Related]
35. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
36. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
Schneider EM; Pawelec GP; Liangru S; Wernet P
J Immunol; 1984 Jul; 133(1):173-9. PubMed ID: 6609974
[TBL] [Abstract][Full Text] [Related]
37. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
[TBL] [Abstract][Full Text] [Related]
38. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
[TBL] [Abstract][Full Text] [Related]
39. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
40. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
